Leishmania donovani BPK282A1 complete genome, chromosome 5.
Eukaryota; Euglenozoa; Kinetoplastida; Trypanosomatidae; Leishmaniinae; Leishmania.
Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance
Submitted (30-MAR-2018) National Center for Biotechnology Information, NIH, Bethesda, MD 20894, USA
Submitted (25-JAN-2011) Aslett M., Pathogen Sequencing Unit, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, Cambridgeshire CB10 1SA, UNITED KINGDOM
PROVISIONAL REFSEQ: This record has not yet been subject to final\nNCBI review. The reference sequence is identical to FR799592.\nData release policy http://www.sanger.ac.uk/legal/#t_2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: INSDC submitter\nAnnotation Status :: Full annotation\nAnnotation Pipeline :: Eukaryotic Annotation Propagation Pipeline\n##Genome-Annotation-Data-END##
paraflagellar rod component par4, putative
dihydrolipoamide branched chain transacylase, putative
dual specificity phosphatase-like protein
viscerotropic leishmaniasis antigen, putative
phosphate carrier protein, mitochondrial precursor-like protein
DNA replication licensing factor, putative
microtubule-associated protein, putative
structural maintenance of chromosome (SMC), putative
monocarboxylate transporter-like protein
nuclear receptor binding factor-like protein
kinetoplast-associated protein-like protein
MYND zinc finger (ZnF) domain-like protein
methylthioadenosine phosphorylase, putative
NADH-ubiquinone oxidoreductase, mitochondrial, putative
double-strand-break repair protein rad21 homolog, putative
elongation of very long chain fatty acids protein, putative
protein phosphatase type 1 regulator-like protein